Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines.
作者信息
den Heijer Jonas M, Heuberger Jules A A C, Hijma Hemme, Kruithof Annelieke C, van Smeden Jeroen, Groeneveld Geert Jan, Burggraaf Jacobus, Cohen Adam
机构信息
Clinical Pharmacology, Centre for Human Drug Research, Leiden, The Netherlands.
Clinical Pharmacology, Leiden University Medical Center, Leiden, The Netherlands.
出版信息
Br J Clin Pharmacol. 2021 Dec;87(12):4552-4559. doi: 10.1111/bcp.14843. Epub 2021 May 3.
Abstract
摘要
相似文献
1
Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines.通过消除对《药物临床试验质量管理规范》指南的防御性解读来进行良好的临床试验。
Br J Clin Pharmacol. 2021 Dec;87(12):4552-4559. doi: 10.1111/bcp.14843. Epub 2021 May 3.
2
[Who should carry out the bureaucracy in the medical practice?].[医疗实践中的官僚作风应由谁来执行？]
Aten Primaria. 1994 May 31;13(9):516.
3
Prevalence and costs of defensive medicine: a national survey of Italian physicians.防御性医疗的患病率及成本：意大利医生的全国性调查
J Health Serv Res Policy. 2017 Oct;22(4):211-217. doi: 10.1177/1355819617707224. Epub 2017 May 23.
4
Good clinical practice in the European Union.欧盟的良好临床实践。
Hum Gene Ther. 2008 May;19(5):441-2. doi: 10.1089/hum.2008.0409.
5
Defensive medicine: Everything and its opposite.防御性医疗：包罗万象又自相矛盾。
Eur J Intern Med. 2020 Apr;74:117-118. doi: 10.1016/j.ejim.2020.01.015. Epub 2020 Jan 28.
6
Expected-utility perspectives on defensive testing. Torts, tradeoffs, and thresholds--is defensive medicine defensible?
Med Decis Making. 1998 Jan-Mar;18(1):29-31. doi: 10.1177/0272989X9801800106.
7
Good clinical practice standards: what they are and some tools to support them.良好临床实践标准：其内容及一些支持工具。
Hum Gene Ther. 2008 May;19(5):431-40. doi: 10.1089/hum.2008.0508.
8
The determinants of defensive medicine practices in Belgium.比利时防御性医疗行为的决定因素。
Health Econ Policy Law. 2017 Jul;12(3):363-386. doi: 10.1017/S174413311600030X. Epub 2016 Nov 22.
9
Defensive medicine: Sword of Damocles.防御性医疗：达摩克利斯之剑。
Natl Med J India. 2018 Nov-Dec;31(6):364-365. doi: 10.4103/0970-258X.262898.
10
Defensive medicine versus value-based care.
Med Econ. 2016 Mar 25;93(6):17-8, 20-2.
引用本文的文献
1
Exploration of current situation of psychotropic drugs research and development in China based on drug clinical trials.基于药物临床试验的中国精神药物研发现状探索
Front Psychiatry. 2025 Jul 15;16:1599038. doi: 10.3389/fpsyt.2025.1599038. eCollection 2025.
2
Sustainable Innovations in Food Microbiology: Fermentation, Biocontrol, and Functional Foods.食品微生物学中的可持续创新：发酵、生物防治与功能食品。
Foods. 2025 Jun 30;14(13):2320. doi: 10.3390/foods14132320.
3
Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS-CoV-2.采用人因工程学于早期阶段和实验医学研究：嵌套式初步研究观察 SARS-CoV-2 的人体感染控制。
Br J Clin Pharmacol. 2024 Jul;90(7):1586-1599. doi: 10.1111/bcp.15949. Epub 2023 Nov 22.
本文引用的文献
1
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
2
Reducing Bureaucracy in Clinical Research: A Call for Action.减少临床研究中的官僚作风：行动呼吁。
Hemasphere. 2020 Feb 26;4(2):e352. doi: 10.1097/HS9.0000000000000352. eCollection 2020 Apr.
3
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.2009-2018 年新药推向市场所需的研发投资估算。
JAMA. 2020 Mar 3;323(9):844-853. doi: 10.1001/jama.2020.1166.
4
The Magic of Randomization versus the Myth of Real-World Evidence.随机化的魔力与真实世界证据的神话
N Engl J Med. 2020 Feb 13;382(7):674-678. doi: 10.1056/NEJMsb1901642.
5
Bureaucracy is strangling clinical research.官僚主义正在扼杀临床研究。
BMJ. 2019 Mar 13;364:l1097. doi: 10.1136/bmj.l1097.
6
Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.2015-2016 年美国食品和药物管理局批准的新型治疗药物关键性试验的预估成本。
JAMA Intern Med. 2018 Nov 1;178(11):1451-1457. doi: 10.1001/jamainternmed.2018.3931.
7
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.利伐沙班治疗心力衰竭伴窦性节律和冠心病患者的疗效。
N Engl J Med. 2018 Oct 4;379(14):1332-1342. doi: 10.1056/NEJMoa1808848. Epub 2018 Aug 27.
8
The impact of data errors on the outcome of randomized clinical trials.数据错误对随机临床试验结果的影响。
Clin Trials. 2017 Oct;14(5):499-506. doi: 10.1177/1740774517716158. Epub 2017 Jun 22.
9
Improving public health by improving clinical trial guidelines and their application.通过改进临床试验指南及其应用来改善公众健康。
Eur Heart J. 2017 Jun 1;38(21):1632-1637. doi: 10.1093/eurheartj/ehx086.
10
Innovation in the pharmaceutical industry: New estimates of R&D costs.制药行业的创新：研发成本的新估计
J Health Econ. 2016 May;47:20-33. doi: 10.1016/j.jhealeco.2016.01.012. Epub 2016 Feb 12.
Zotero 插件